vers la météo de la validation par utilisateur

Ingenuity174


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 24 - PMID ?

In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 1
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 2
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 3
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 4
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           |                                      |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 5
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 6
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 7
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 8
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 9
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 10
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    |                                                                           +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 11
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 12
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 13
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+                           |                                      +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 14
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           |                                      +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 15
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 16
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 17
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 18
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 19
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 20
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 21
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 22
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 23
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 24
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 25
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 26
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 27
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 28
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 29
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 30
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 31
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 32
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 33
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 34
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 35
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 36
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+                           |                                      |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 37
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 38
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 39
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 40
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 41
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 42
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 43
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 44
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 45
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 46
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 47
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 48
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 49
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 50
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 51
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 52
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 53
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 54
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 55
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 56
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                           |                                      |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 57
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 58
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------APPOS---------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                           |                                      |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,decrease)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 59
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------APPOS--------------------------------------------------------+                                      |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                           |                                      |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                           |                                      |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                           |                                      |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,decrease)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 60
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +-------------------------------------------------------APPOS-------------------------------------------------------+                                                       |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+          |                                                       |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,__NODE__)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 61
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         |                    +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 62
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +------------------------------------------------APPOS------------------------------------------------+                                                       |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+          |                                                       |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,__NODE__)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 63
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +------------------------------------------------APPOS------------------------------------------------+                                                       |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+          |                                                       |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,__NODE__)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 64
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +-------------------------------------------------------APPOS-------------------------------------------------------+                                                       |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+          |                                                       |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |          |                                                       |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,__NODE__)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 65
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------APPOS---------------------------------------------------------------+                                      |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                           |                                      |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                           |                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                           |                                      |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,decrease)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 66
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 67
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 68
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 69
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 70
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 71
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                           +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 72
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 73
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 74
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 75
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 76
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +------------------COMP:N-N(of)-----------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 77
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 78
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 79
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 80
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 81
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 82
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 83
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 84
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 85
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 86
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 87
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         |                    +----------------------COMP:N-N(of)---------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         |                    +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 88
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                                                                  |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 89
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                              +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 90
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 91
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 92
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 93
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 94
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 95
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 96
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 97
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 98
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 99
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 100
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 101
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 102
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 103
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 104
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 105
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 106
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 107
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 108
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 109
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 110
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 111
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 112
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 113
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 114
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 115
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                                                        
    |                                                                           +-------------------------------APPOS------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
APPOS (chimera,__NODE__)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 116
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 117
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 118
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +-------------------------------------------------------APPOS-------------------------------------------------------+                                                       |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+          |                                                       |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,__NODE__)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 119
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------APPOS---------------------------------------------------------------+                                      |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                           |                                      |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                           |                                      |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                           |                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                           |                                      +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,decrease)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 120
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +------------------------------------------------APPOS------------------------------------------------+                                                       |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+          |                                                       |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,__NODE__)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 121
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 122
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 123
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 124
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 125
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 126
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 127
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |                                                                          |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 128
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 129
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +---------------------------------COMP:N-N(of)---------------------------------+                                                                          |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               |                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |                                                                          |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 130
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                                           +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                                           +----------------------COMP:N-N(of)---------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                                           +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+--OBJ:V-N--+                              |                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,chimera)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 131
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 132
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 133
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                                                                  |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |                                                                  |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 134
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 135
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 136
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 137
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 138
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 139
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 140
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 141
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 142
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 143
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 144
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 145
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 146
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 147
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 148
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 149
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 150
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------APPOS--------------------------------------------------------+                                      |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                           |                                      |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                           |                                      |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,decrease)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 151
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 152
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 153
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 154
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 155
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 156
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 157
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 158
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+                                                                          +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 159
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------COMP:N-N(of)---------------------------------+       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,__NODE__)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 160
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 161
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                                                                  |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 162
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                                                                  |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 163
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 164
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 165
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                                                                  |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 166
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          +----------OBJ:V-N----------+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
SUBJ:V_PASS-N (treat,acid)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 167
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 168
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 169
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 170
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 171
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 172
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 173
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 174
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 175
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 176
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 177
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 178
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 179
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 180
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 181
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 182
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 183
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 184
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 185
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 186
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                                                +----------COMP:N-N(of)---------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 187
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 188
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 189
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 190
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 191
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 192
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 193
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 194
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 195
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 196
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +------------------------------------------------APPOS------------------------------------------------+                                                       |                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+          |                                                       |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
APPOS (1,__NODE__)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 197
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +-------------------------------------------------------APPOS-------------------------------------------------------+                                                       |                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+          |                                                       |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |          |                                                       |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |          |                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
APPOS (acid,__NODE__)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 198
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                           +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 199
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                              +----------------------COMP:N-N(of)---------------------+                           +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 200
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 201
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 +-------------------------------------COMP:N-N(of)-------------------------------------+                                                                  |                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 202
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 203
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 204
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 205
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 206
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------------------------------------------SUBJ:V-N---------------------------------------------------------------------------------+                                                                                                                        
    |                          +----------------------------------------------COMP:N-N(of)----------------------------------------------+                                                                  |                                                                                                                        
    |                          +----------------------------------COMP:N-N(of)----------------------------------+                       |                                                                  |                                                                                                                        
    |                          +-------------------------OBJ:V-N-------------------------+                      |                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    |                          |                 +----------------SUBJ:V-N---------------+                      |                       |                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                          +----------OBJ:V-N----------+                             |                      |                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |                          |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:N-N(of) (acid,protein)
COMP:N-N(of) (acid,protein)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,acid)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,acid)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,acid)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 207
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------------------------------------------SUBJ:V-N--------------------------------------------------------------------------+                                                                                                                        
                                           | +---------------------------------------COMP:N-N(of)---------------------------------------+                                                                  |                                                                                                                        
                                           | +---------------------------COMP:N-N(of)---------------------------+                       |                                                                  |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+ +------------------OBJ:V-N------------------+                      |                       |                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+ |   +----------------SUBJ:V-N---------------+                      |                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+ +---OBJ:V-N---+-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+ |   +-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |     | |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
COMP:N-N(of) (1,protein)
COMP:N-N(of) (1,protein)
OBJ:V-N (overproduce,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,1)
SUBJ:V-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,1)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 208
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                              +----------COMP:N-N(of)---------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
COMP:N-N(of) (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 209
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 210
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 211
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                                                   +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 212
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 213
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 214
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 215
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               +-------------------------------COMP:V-N(of)-------------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 216
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                                                    +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 217
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 218
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                                                    +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 219
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 220
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 221
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 222
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 223
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 224
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 225
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 226
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 227
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 228
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 229
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 230
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 231
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------------------COMP:N-N(of)-------------------------------------+                           +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 232
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
                                                 +-------------------------------------COMP:N-N(of)-------------------------------------+                           |                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       |                           |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |                           +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 233
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
                                                 +-------------------------------------COMP:N-N(of)-------------------------------------+                           |                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       |                           |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |                           +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 234
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 235
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 236
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 237
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 238
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 239
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 240
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 241
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 242
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       |          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 243
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 244
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 245
                                                                                                                                                                    +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 246
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 247
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                                                                                                                                            +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |               +-------------------------------COMP:V-N(of)-------------------------------+----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 248
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 249
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 250
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 251
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 252
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 253
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 254
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 255
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 256
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 257
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 258
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 259
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 260
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                                                                          +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 261
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 262
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              |               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 263
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |                                                              +---------------------------------------COMP:V-N(of)---------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                              |               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 264
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 265
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 266
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 267
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 268
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 269
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 270
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 271
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+-------------------------COMP:N-N(of)-------------------------+                                                   +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------SUBJ:V_PASS-N-------------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 272
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 273
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                                                          |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 274
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 275
    +----------------MOD_ATT:N-ADJ---------------+-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                                      +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 276
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 277
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+                                                                              +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+                                                                              |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 278
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 279
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                                                                                                                                            +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 280
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 281
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 282
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------SUBJ:V_PASS-N-------------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,cell)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 283
                                                 +-------------------------COMP:N-N(of)-------------------------+               +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |               |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 284
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 285
                                                 +-------------------------COMP:N-N(of)-------------------------+                       +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |                       |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 286
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 287
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 288
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 289
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                           |                                      |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 290
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
                                                 +-------------------------------------COMP:N-N(of)-------------------------------------+                           |                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                       |                           |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                       |                           +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                       |                           +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       |                           |              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 291
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 292
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 293
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 294
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 295
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 296
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 297
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 298
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 299
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 300
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                                                    +--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 301
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                           |                                      |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 302
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 303
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
                                           |               +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 304
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 305
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+                   +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V_P+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
SUBJ:V_PASS-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 306
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                           |                                      +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 307
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 308
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                  +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 309
                                                 +-----------------------------------------------------------------------COMP:V-N(In)----------------------------------------------------------------------+                                                                                                                        
                                                 |         +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    +----------------MOD_ATT:N-ADJ---------------+         +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+         +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,cell)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 310
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 311
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 312
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 313
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 314
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  |        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 315
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 316
                                           +--------------------------------------------------------------------------COMP:V-N(In)-------------------------------------------------------------------------+                                                                                                                        
                                           |               +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    +-------------MOD_ATT:N-ADJ------------+               +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            +------MOD_ATT:N-ADJ------+               +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             +MOD_ATT:N-A+               +-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     +MOD_A+     +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |     |     |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (CV,9)
MOD_ATT:N-ADJ (CV,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (CV,acid)
MOD_ATT:N-ADJ (CV,treat)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,CV)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 317
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 318
                                                                                                                                                                    +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
                                                                                                                                                                    +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 319
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 320
    +----------------MOD_ATT:N-ADJ---------------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                                                                          +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 321
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 322
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+                                                              +--------------------COMP:V-N(of)-------------------+---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 323
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 324
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 325
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 326
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 327
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 328
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 329
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 330
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 331
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 332
    +----------------MOD_ATT:N-ADJ---------------+                                                                                                                                                                                                                                           +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+---------------------------------------------------COMP:V-N(In)---------------------------------------------------+--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+-------------------------COMP:N-N(of)-------------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+----------------OBJ:V-N----------------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+-SUBJ:V-N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
SUBJ:V-N (overproduce,cell)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 333
                                                 +---------------------------------------------------COMP:V-N(In)---------------------------------------------------+                                                                                                                                                               
    +----------------MOD_ATT:N-ADJ---------------+-------------------------COMP:N-N(of)-------------------------+                                                   |                                                                                                                        +--------------OBJ:V-N-------------+   
    |            +---------MOD_ATT:N-ADJ---------+----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             +--MOD_ATT:N-ADJ--+         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     +MOD_ATT:N-A+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (cell,9)
MOD_ATT:N-ADJ (cell,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (cell,acid)
MOD_ATT:N-ADJ (cell,treat)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,cell)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 334
                                                 +-------------------------COMP:N-N(of)-------------------------+                                                                                                                                                                            +--------------OBJ:V-N-------------+   
                                                 +----------------OBJ:V-N----------------+                      |                                                   +--------------------OBJ:V-N--------------------+                                                                        |       +-------MOD_ATT:N-ADJ------+   
                                                 |         +-----------SUBJ:V-N----------+                      |                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+--OBJ:V-N--+         +-------OBJ:V-N------+        |          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       +MOD+         |            +MOD_ATT+        |          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,cell)
MOD_ATT:N-N (cell,1)
COMP:N-N(of) (cell,protein)
OBJ:V-N (overproduce,chimera)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,cell)
SUBJ:V-N (compose,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 335
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       +----------------------------COMP:V-N(with)----------------------------+          |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:V-N(with) (trans,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 336
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 337
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------APPOS-------------------------------------------------+                                      |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                           |                                      |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |                           |                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,decrease)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 338
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       +-----------APPOS-----------+                                      |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +--MOD_ATT:N-ADJ-+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +MOD_ATT:+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,decrease)
MOD_ATT:N-ADJ (decrease,__NODE__)
MOD_ATT:N-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 339
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |            +--------------MOD_ATT:N-ADJ--------------+--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |            |             +-------MOD_ATT:N-ADJ-------+--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
    |            |             |     +----MOD_ATT:N-ADJ----+--------------------COMP:N-N(of)--------------------+                       |                                                                  |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    |            |             |     |       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            |             |     |       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (overproduce,hydroxyoctadecadienoic)
MOD_ATT:N-ADJ (overproduce,acid)
MOD_ATT:N-ADJ (overproduce,treat)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 340
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 341
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 342
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 343
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 344
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+        +------------------------COMP:N-N(with)-----------------------+          |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 345
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                       |          +------------------------SUBJ:V-N-----------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 346
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-N (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 347
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                                                        
    |                                                      +-----------------------------------------APPOS-----------------------------------------+                                                       |                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+          |                                                       |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |          |                                                       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
APPOS (overproduce,__NODE__)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 348
    +---------------------------------------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------------------------------------+                                                                                                                        
    |                                                      +--------------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
    |                                                      +--------------------------------COMP:N-N(of)--------------------------------+                                                                  |                                                                                 |       +-------MOD_ATT:N-ADJ------+   
    |                                                      +--------------------COMP:N-N(of)--------------------+                       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +-------------OBJ:V-N------------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
OBJ:V-N (treat,9)
SUBJ:V-N (treat,acid)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(In) (trans,9)
SUBJ:V-N (trans,overproduce)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 349
                                                                                                                                        +---------------------------COMP:V-N(of)---------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                        |          +------------------------SUBJ:V-N-----------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                       |          |                +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          |       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,protein)
SUBJ:V-N (trans,__NODE__)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 350
                                                                                                                                                                                                                                                                                             +--------------OBJ:V-N-------------+   
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+               |       +-----------------------------SUBJ:V-N-----------------------------+        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 351
                                                                                                                                +-------------------------------COMP:V-N(of)-------------------------------+                                                                                 +--------------OBJ:V-N-------------+   
                                                                                                                                |       +-----------------------------SUBJ:V-N-----------------------------+                                         +----------------SUBJ:V-N---------------+       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+               |       |                           +---------COMP:V-N(in)---------+       |        +----------COMP:N-N(of)----------+-------COMP:N-N(with)-------+          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+               |       |          +-----OBJ:V-N----+              +--MOD_ATT:N-N--+       |        |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               |       +---APPOS--+       +SUBJ:V-N+              |      +MOD_ATT:+       +-OBJ:V-N+               |         +MOD_AT+          |       +MOD_ATT:N+          |       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
APPOS (protein,__NODE__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
COMP:V-N(of) (trans,__NODE__)
SUBJ:V-N (trans,protein)
OBJ:V-N (trans,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)

Analyse 352
                                                                                                                                                                    +------------------------------------------------COMP:V-N(with)-----------------------------------------------+          +--------------OBJ:V-N-------------+   
                                                                                                                                                                    +--------------------OBJ:V-N--------------------+                                                             |          |       +-------MOD_ATT:N-ADJ------+   
                                     +-------OBJ:V-N-------+--------------------COMP:N-N(of)--------------------+                                                   +---------COMP:V-N(in)---------+                +----------COMP:N-N(of)----------+                            |          |       |     +-----MOD_ATT:N-N----+   
    +----------COMP:V-N(In)----------+       +-MOD_ATT:N-N-+-----------OBJ:V-N-----------+          +MOD_ATT:N-A+                       +--------COMP:V-N(of)-------+              +--MOD_ATT:N-N--+                |               +---MOD_ATT:N-N--+          +---MOD_ATT:N-N---+          |       |     |     +--MOD_ATT:N-N-+   
    |            +MOD_ATT:N-ADJ+SUBJ:+       |   +MOD_ATT:N+            +MOD_ATT+SUBJ:V-N+          |     +MOD_A+               +MOD_ATT+          +MOD_ATT+SUBJ:V-N+              |      +MOD_ATT:+       +MOD_ATT:+               |         +MOD_AT+          |       +MOD_ATT:N+-SUBJ:V-N-+       |     |     |       +MOD_AT+   
    |            |             |     |       |   |         |            |       |        |          |     |     |               |       |          |       |        |              |      |        |       |        |               |         |      |          |       |         |          |       |     |     |       |      |   
 In 9 hydroxyoctadecadienoic acid treated CV 1 cells overproducing a protein chimera composed of __SP__ Gal4 protein and of __NODE__ protein , __NODE__ protein decreases ( in a dose dependent manner ) trans activation of a luciferase reporter gene with a DNA endogenous promoter that has a __SP__ Gal4 protein binding site .
MOD_ATT:N-ADJ (acid,hydroxyoctadecadienoic)
COMP:V-N(In) (treat,9)
SUBJ:V-N (treat,acid)
OBJ:V-N (treat,overproduce)
MOD_ATT:N-N (overproduce,1)
MOD_ATT:N-N (overproduce,cell)
COMP:N-N(of) (overproduce,protein)
MOD_ATT:N-N (chimera,protein)
OBJ:V-N (compose,overproduce)
SUBJ:V-N (compose,chimera)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,Gal4)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(of) (decrease,protein)
SUBJ:V-N (decrease,protein)
COMP:V-N(in) (decrease,manner)
OBJ:V-N (decrease,activation)
COMP:V-N(with) (decrease,promoter)
MOD_ATT:N-N (manner,dose)
MOD_ATT:N-ADJ (manner,dependent)
MOD_ATT:N-N (activation,trans)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-N (promoter,DNA)
MOD_ATT:N-ADJ (promoter,endogenous)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__SP__)
MOD_ATT:N-N (site,Gal4)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,bind)